🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust trade exists on messaging services, where groups with numerous of members share comparison images, injection guides and assertions of next-day British shipping. Sellers market the drug there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Voice Concerns

However, physicians and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users injecting products of uncertain source.

Some experts stated the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.

Some content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to fines, prosecution or prison.

Platform Response and Content Removal

According to TikTok, the platform has removed problematic material and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Trading Operations

Research also discovered groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, filled with images of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at residence.

After minutes of entering one group, a vendor shared contact information, where the majority of transactions take place. The vendor provided an instruction manual and promised delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.

Item Information and Costs

Within these groups, posts show dark colored parcels with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for Telegram said it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental product not yet approved … may subject users to potentially significant health risks”.